EUCTR2021-000880-63-SE进行中（未招募）1 期
COVID-19 vaccine in patients with inflammatory rheumatic diseases: The impact of immunomodulating treatments on the antibody response, T cells response and protection against infection (COVID19-REUMA) - COVID19-REUMA
Skåne University Hospital, department of rheumatology in Lud and Malmö0 个研究点目标入组 868 人开始时间: 2021年2月23日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 868
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •-age>18 years
- •-having regularly follow up at any of participating rheumatology centra
- •-receiving immunomodulating treatment above for at least 3 months ( only for patients)
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 500
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 368
排除标准
- •-receiving immunomodulating treatment for other conditions than rheumatic disease
- •-pregnancy
- •-changes of immunomodulating treatment four weeks before the vaccination
- •-not willing to get vaccinated against COVID19
- •-ongoing COVID19 or other infection
研究者
相似试验
已完成
不适用
Covid-19 Vaccination in Patients with Inflammatory Bowel DiseasesInflammatory Bowel DiseasesDRKS00025694Medizinische Hochschule Hannover23
进行中（未招募）
1 期
COVID-19 vaccine induced immune response in patients with primary antibody deficiencyCOVID-19EUCTR2021-004891-33-FITurku University Hospital50
已完成
不适用
Humoral and Cellular Immune Response to COVID-19 Vaccines in Immunocompromised and Healthy IndividualsCovid19ImmunosuppressionNCT04858607Medical University of Graz373
终止
早期 1 期
COVID-19 Vaccination in Rheumatic Disease PatientsSystemic Lupus ErythematosusInflammatory MyositisGoutArthritis of Multiple Sites Associated With Inflammatory Bowel Disease (Diagnosis)OsteoarthritisAnkylosing SpondylitisPsoriatic ArthritisSjogren's SyndromeNCT04839315Mayo Clinic58
已完成
不适用
Vaccination Against SARS-Cov2 (COVID-19) in Chronic Inflammatory Rheumatism and Factors Determining Its Decision.Rheumatoid ArthritisSpondyloarthritisNCT04970550Hopital Nord Franche-Comte150